Arkolith/Insider Trading/AVDL/Form 4

Palczuk Linda

DirectorAVADEL PHARMACEUTICALS PLC (AVDL) · full profile →Form 4 · filed Jan 22, 2025
Net Buying
Open-Market Buys
$40K
Open-Market Sells
$0
Net Open-Market Flow
$40K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 21, 2025Buy(P)5K$7.93$40K68K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-25-005248) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML